Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abbas E Kitabchi

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Diabetes|July 19, 2013
Prevention of diabetes with pioglitazone in ACT NOW: physiologic correlatesRalph A Defronzo, Devjit Tripathy, Dawn C Schwenke, et al.
Diabetes Care|September 25, 2013
Prediction of diabetes based on baseline metabolic characteristics in individuals at high riskRalph A Defronzo, Devjit Tripathy, Dawn C Schwenke, et al.
Age (Dordrecht, Netherlands)|September 3, 2016
Pioglitazone is equally effective for diabetes prevention in older versus younger adults with impaired glucose toleranceSara E Espinoza, Chen-Pin Wang, Devjit Tripathy, et al.
The New England Journal of Medicine|March 25, 2011
Pioglitazone for diabetes prevention in impaired glucose toleranceRalph A DeFronzo, Devjit Tripathy, Dawn C Schwenke, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 24, 2012
Pioglitazone slows progression of atherosclerosis in prediabetes independent of changes in cardiovascular risk factorsAramesh Saremi, Dawn C Schwenke, Thomas A Buchanan, et al.
The Journal of Clinical Endocrinology and Metabolism|January 21, 2015
A novel insulin resistance index to monitor changes in insulin sensitivity and glucose tolerance: the ACT NOW studyDevjit Tripathy, Jeff E Cobb, Walter Gall, et al.
Diabetes Care|March 17, 2007
Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial, Xavier Pi-Sunyer, George Blackburn, et al.
Diabetes Care|August 23, 2014
Impact of an intensive lifestyle intervention on use and cost of medical services among overweight and obese adults with type 2 diabetes: the action for health in diabetesMark A Espeland, Henry A Glick, Alain Bertoni, et al.
Obesity (Silver Spring, Md.)|January 4, 2020
History of Cardiovascular Disease, Intensive Lifestyle Intervention, and Cardiovascular Outcomes in the Look AHEAD Trial, Cora E Lewis, John P Bantle, et al.
The New England Journal of Medicine|June 26, 2013
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes, Rena R Wing, Paula Bolin, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Diabetes|July 19, 2013
Prevention of diabetes with pioglitazone in ACT NOW: physiologic correlatesRalph A Defronzo, Devjit Tripathy, Dawn C Schwenke, et al.
Diabetes Care|September 25, 2013
Prediction of diabetes based on baseline metabolic characteristics in individuals at high riskRalph A Defronzo, Devjit Tripathy, Dawn C Schwenke, et al.
Age (Dordrecht, Netherlands)|September 3, 2016
Pioglitazone is equally effective for diabetes prevention in older versus younger adults with impaired glucose toleranceSara E Espinoza, Chen-Pin Wang, Devjit Tripathy, et al.
The New England Journal of Medicine|March 25, 2011
Pioglitazone for diabetes prevention in impaired glucose toleranceRalph A DeFronzo, Devjit Tripathy, Dawn C Schwenke, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 24, 2012
Pioglitazone slows progression of atherosclerosis in prediabetes independent of changes in cardiovascular risk factorsAramesh Saremi, Dawn C Schwenke, Thomas A Buchanan, et al.
The Journal of Clinical Endocrinology and Metabolism|January 21, 2015
A novel insulin resistance index to monitor changes in insulin sensitivity and glucose tolerance: the ACT NOW studyDevjit Tripathy, Jeff E Cobb, Walter Gall, et al.
Diabetes Care|March 17, 2007
Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial, Xavier Pi-Sunyer, George Blackburn, et al.
Diabetes Care|August 23, 2014
Impact of an intensive lifestyle intervention on use and cost of medical services among overweight and obese adults with type 2 diabetes: the action for health in diabetesMark A Espeland, Henry A Glick, Alain Bertoni, et al.
Obesity (Silver Spring, Md.)|January 4, 2020
History of Cardiovascular Disease, Intensive Lifestyle Intervention, and Cardiovascular Outcomes in the Look AHEAD Trial, Cora E Lewis, John P Bantle, et al.
The New England Journal of Medicine|June 26, 2013
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes, Rena R Wing, Paula Bolin, et al.
Pageof 8